Recruiting Diffuse Large B-Cell Lymphoma Studies in New York
About Diffuse Large B-Cell Lymphoma Clinical Trials in New York
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, accounting for about 30% of cases. It is an aggressive lymphoma that grows rapidly. Treatment usually involves chemoimmunotherapy, with CAR-T cell therapy for relapsed cases.
There are currently 2 diffuse large b-cell lymphoma clinical trials recruiting participants in New York, NY. These studies are seeking a combined 62 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center, AIDS Malignancy Consortium. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diffuse Large B-Cell Lymphoma Clinical Trials in New York — FAQ
Are there diffuse large b-cell lymphoma clinical trials in New York?
Yes, there are 2 diffuse large b-cell lymphoma clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What diffuse large b-cell lymphoma treatments are being tested?
The 2 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for diffuse large b-cell lymphoma.
Data updated October 16, 2026 from ClinicalTrials.gov